Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tavanic 500mg tablets
0501120X0BBAAAA
|
Tavanic | Levofloxacin | Infections | No data available |
|
Tavanic 500mg/100ml solution for infusion vials
0501120X0BBACAC
|
Tavanic | Levofloxacin | Infections | No data available |
|
Tavegil 500micrograms/5ml elixir
0304010H0BBABAA
|
Tavegil | Clemastine fumarate | Respiratory System | No data available |
|
Taxceus 140mg/7ml concentrate for inf vials
0801050D0BCACAH
|
Taxceus | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxceus 20mg/1ml concentrate for solution for infusion vials
0801050D0BCAAAC
|
Taxceus | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxceus 80mg/4ml concentrate for solution for infusion vials
0801050D0BCABAD
|
Taxceus | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxol 100mg/16.7ml solution for infusion vials
0801050V0BBABAB
|
Taxol | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxol 150mg/25ml solution for infusion vials
0801050V0BBADAC
|
Taxol | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxol 300mg/50ml solution for infusion vials
0801050V0BBACAD
|
Taxol | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxol 30mg/5ml solution for infusion vials
0801050V0BBAAAA
|
Taxol | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxotere 160mg/8ml concentrate for inf vials
0801050D0BBAEAI
|
Taxotere | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxotere 20mg/0.5ml solution for infusion vials and diluent
0801050D0BBAAAA
|
Taxotere | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxotere 20mg/1ml concentrate for inf vials
0801050D0BBACAC
|
Taxotere | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxotere 80mg/2ml solution for infusion vials and diluent
0801050D0BBABAB
|
Taxotere | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxotere 80mg/4ml concentrate for inf vials
0801050D0BBADAD
|
Taxotere | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Tazocin 2g/0.25g powder for solution for infusion vials
0501014S0BBAAAA
|
Tazocin | Piperacillin sodium/tazobactam sodium | Infections | No data available |
|
Tazocin 4.5g inj intravenous infusion pack
0501014S0BBACAC
|
Tazocin | Piperacillin sodium/tazobactam sodium | Infections | No data available |
|
Tazocin 4g/0.5g powder for solution for infusion vials
0501014S0BBABAB
|
Tazocin | Piperacillin sodium/tazobactam sodium | Infections | No data available |
|
TCP antiseptic ointment
131001100BNBAA0
|
Proprietary compound preparation BNF 1310011 | Other topical only antibacterial preparations | Skin | No data available |
|
TCP first aid antiseptic cream
131005000BBBMA0
|
Proprietary compound preparation BNF 1310050 | Other minor cut and abrasion preparations | Skin | No data available |
|
TCP Sore Throat 2.4mg lozenges
1203030J0BDAAAA
|
TCP (Lozenges) | Hexylresorcinol | Ear, Nose and Oropharynx | No data available |
|
Teangi Tea Tree & Witch Hazel cream
190205500BCETA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Tearmos eye drops
21300000307
|
Tearmos eye drops | Eye Products | Appliances | No data available |
|
Tecfidera 240mg gastro-resistant capsules
0802040AKBBABAB
|
Tecfidera | Dimethyl fumar | Malignant Disease and Immunosuppression | No data available |
|
Tedizolid 200mg powder for solution for infusion vials
0501070ADAAAAAA
|
Tedizolid | Tedizolid | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.